Skip to content
ChatProjectCodes

Earlier editions: 2020-112018-112026-09

DIVISION 10.5. ALCOHOL AND OTHER DRUG PROGRAMS 11750-11975›PART 2. STATE GOVERNMENT'S ROLE TO ALLEVIATE PROBLEMS RELATED TO THE INAPPROPRIATE USE OF ALCOHOLIC BEVERAGES AND OTHER DRUG USE 11760-11872›CHAPTER 10. Narcotic Treatment Programs 11839-11839.34›ARTICLE 1. Narcotic Treatment Programs 11839-11839.22

§ 11839.2

California Health and Safety Code · 2026-10 edition · updated 2026-10-04 · California

The following medications are authorized for use in narcotic replacement therapy and medication-assisted treatment by licensed narcotic treatment programs:

(a) Methadone.

(b) Buprenorphine products or combination of products approved by the federal Food and Drug Administration for treatment of opioid dependence.

(c) Any other medication approved by the federal Food and Drug Administration for the purpose of narcotic replacement treatment or medication-assisted treatment of substance use disorders.

(d) Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section by means of plan or provider bulletins, or similar instructions. The department shall adopt regulations by no later than January 1, 2021.

(Amended by Stats. 2026, Ch. 27, Sec. 35. (SB 164) Effective June 29, 2026.)

Get a plain-English answer with a citation back to this text.

Ask AI about this code
Export this section
▸Contents — California Health and Safety Code
California Health and Safety Code

GoCodebook provides public access, search, citation, multilingual explanation, and practical interpretation of legally adopted building regulations. It is not a substitute for the official ICC or California code publications.